ODYSSEY: A randomized, double-blind, placebo-controlled study to investigate the efficacy of tradipitant in treating inflammatory lung injury and improving clinical outcomes associated with severe COVID-19 infection
This Study is
No Longer Enrolling
The tradipitant therapy is being studied to explore if the administration prevents or treats the cytokine storm and acute respiratory distress syndrome leading to respiratory failure and high mortality in affected patients with COVID-19.
Adult
Adults aged 18-90 with confirmed laboratory COVID-19 infection and hospitalized for treatment.
Patients participating in other clinical trials are excluded
Treatment
National
Memorial Hospital Central
Memorial Hospital North
Protocol Number: 20-6506
More information available at ClinicalTrials.gov: NCT04326426
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers